Guardant Health Sees Prelim. Q4 Revenue $153M-$154M vs $146.34M Est., FY23 Revenue $562M-$563M vs $555.18M Est.
Portfolio Pulse from Benzinga Newsdesk
Guardant Health reported preliminary Q4 revenue of $153M-$154M, surpassing the estimate of $146.34M. For FY23, the company expects revenue of $562M-$563M, also exceeding the forecast of $555.18M.
January 08, 2024 | 2:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guardant Health's preliminary Q4 revenue and FY23 revenue forecast exceed analysts' estimates, indicating strong financial performance.
Guardant Health's reported preliminary revenues for Q4 and the forecast for FY23 are both higher than analyst estimates, which is a positive signal for investors and could lead to a short-term increase in the stock price due to better-than-expected financial performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100